KinBio is a rapidly growing biotechnology company based in Rehovot, Israel focusing on developing biopharmaceuticals. Through our experienced team members, KinBio has fostered and developed a large portfolio of technologies for manufacturing generic versions of complex drugs, high quality biosimilars and biologics. 

Augmented by our global partnerships, KinBio is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoperosis. 

Our state of the art cGMP manufacturing plants consists of separate suites for the manufacturing of multi-product biologics bulk drug substances (BDS) and chemical synthesis active pharmaceutical ingredients (APIs) through FDA approved fully fledged sterile drug products  plants. 


Biotechnology

KinBio

Yehudit Dolitzky יהודית דוליצקי

Gila Meles Cohen

Adi Atias Michaeli

The Engineering Team at KinBio plays a pivotal role in ensuring the seamless operation and compliance of the manufacturing processes for biopharmaceuticals. Comprising QA and Process Engineers, the team focuses on maintaining quality assurance, optimizing operations, and implementing process improvements to enhance the production of complex drugs and biosimilars. Their expertise ensures that all systems meet stringent regulatory standards while supporting the company's mission to deliver high-quality therapeutics across various therapeutic areas.

KinBio

Org chart

Teams

Engineering Team

Offices

KinBio

Org chart

Teams

Engineering Team

Offices

Related companies